Overview

Compare PK and Bioavailability of 2 NP101 Patches With Oral Imitrex in Healthy Adults

Status:
Completed
Trial end date:
2010-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this research is to: 1. Compare two study patches having minor differences in patch components 2. Compare the pharmacokinetics (PK - how the body absorbs, metabolizes and eliminates medication) of NP101 (study patches) versus a currently approved oral formulation of Imitrex 3. Collect resistance data during application of NP101 (study patch)
Phase:
Phase 1
Details
Lead Sponsor:
NuPathe Inc.
Treatments:
Sumatriptan